摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(4-fluoro)phenyl-S-phenyl-S-methylsulfoximine | 1140233-93-7

中文名称
——
中文别名
——
英文名称
N-(4-fluoro)phenyl-S-phenyl-S-methylsulfoximine
英文别名
(4-Fluorophenyl)imino-methyl-oxo-phenyl-lambda6-sulfane;(4-fluorophenyl)imino-methyl-oxo-phenyl-λ6-sulfane
N-(4-fluoro)phenyl-S-phenyl-S-methylsulfoximine化学式
CAS
1140233-93-7
化学式
C13H12FNOS
mdl
——
分子量
249.309
InChiKey
FSYCTHZHAQITQA-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    17
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    37.8
  • 氢给体数:
    0
  • 氢受体数:
    3

反应信息

  • 作为产物:
    描述:
    4-氟苯硼酸(甲基亚砜亚胺基)苯4-二甲氨基吡啶copper(l) iodide 作用下, 以 甲醇 为溶剂, 反应 0.75h, 以86%的产率得到N-(4-fluoro)phenyl-S-phenyl-S-methylsulfoximine
    参考文献:
    名称:
    在温和条件下铜催化的亚砜基亚砜与亚砜基亚砜的亚甲基化
    摘要:
    抽象的 在室温下,使用碘化亚铜(I)和4-DMAP可将亚砜基与不同的芳基硼酸(包括位阻硼酸)进行N-芳基化反应。此外,首次证明了生物学上相关的1-甲硫氨酸亚磺酰亚胺的N-芳基化。所有这些反应在短时间内以优异的产率提供了所需的产物。优化的反应条件非常适合磺胺嘧啶与反式-2-苯基乙烯基硼酸进行N-乙烯基化的任务。 在室温下,使用碘化亚铜(I)和4-DMAP可将亚砜基与不同的芳基硼酸(包括位阻硼酸)进行N-芳基化反应。此外,首次证明了生物学上相关的1-甲硫氨酸亚磺酰亚胺的N-芳基化。所有这些反应在短时间内以优异的产率提供了所需的产物。优化的反应条件非常适合磺胺嘧啶与反式-2-苯基乙烯基硼酸进行N-乙烯基化的任务。
    DOI:
    10.1055/s-0037-1612216
点击查看最新优质反应信息

文献信息

  • Copper-catalyzed denitrogenative N-arylation of sulfoximines and sulfonamides with arylhydrazines
    作者:Wanrong Dong、Chaoyang Liu、Xinchi Ma、Yingjun Zhang、Zhihong Peng、Dexun Xie、Delie An
    DOI:10.1016/j.tet.2019.05.039
    日期:2019.7
    A Cu-mediated ligand-free arylation of NH-sulfoximines and sulfonamides by arylhydrazine hydrochlorides was herein demonstrated. The oxidative transformation provided an easy access towards N-aryl sulfoximines and sulfonamides in high yields (up to 93% yields) with broad functional groups tolerance (up to 36 examples). The protocol was proposed to take place through the free radical pathway based on
    本文证明了芳基盐酸盐的Cu介导的NH-亚砜亚胺和磺酰胺的无配体芳基化。氧化转化提供了高收率(最高93%的收率)和宽泛的官能团耐受性(最多36个实例),可轻松获得N-芳基亚磺酰亚胺和磺酰胺。根据控制反应和EPR分析的结果,提出了通过自由基途径进行实验的方案。
  • Iron-Catalyzed CN Cross-Coupling of Sulfoximines with Aryl Iodides
    作者:Arkaitz Correa、Carsten Bolm
    DOI:10.1002/adsc.200700508
    日期:2008.2.22
    An inexpensive and experimentally simple, iron-catalyzed N-arylation reaction of NH-sulfoximines with aryl iodides is reported. This complementary method to the known palladium- and copper-catalyzed ones features the use of a combination of environmentally friendly FeCl3 and N,N′-dimethylethylenediamine (DMEDA) as catalytic system and allows the efficient preparation of various N-arylsulfoximines in
    据报道,一种廉价且实验上简单的,催化的NH-亚磺酰亚胺与芳基化物的N-芳基化反应。这种与已知的催化方法互补的方法,其特征在于使用环保的FeCl 3和N,N'-二甲基乙二胺DMEDA)的组合作为催化体系,并可以高产率高效地制备各种N-芳基亚砜基。
  • Ligand-to-Copper Charge-Transfer-Enabled C–H Sulfoximination of Arenes
    作者:Wanqi Su、Peng Xu、Roland Petzold、Jiyao Yan、Tobias Ritter
    DOI:10.1021/acs.orglett.3c00256
    日期:2023.2.17
    photoinduced sulfoximine-to-copper charge-transfer-enabled generation of sulfoximinyl radicals directly from NH-sulfoximines for C–H sulfoximination of arenes via radical addition. Through copper-LMCT, N-arylation of NH-sulfoximines was achieved for the first time using arenes of different electronic structures as the aryl donors.
    在此,我们报道了一种光诱导的亚砜亚胺电荷转移,能够直接从NH-亚砜亚胺生成亚砜亚胺自由基,用于通过自由基加成对芳烃进行 C-H 亚磺酰亚胺化。通过-LMCT,首次使用不同电子结构的芳烃作为芳基供体实现了NH-亚砜亚胺的N-芳基化。
  • Sulfoximines from a Medicinal Chemist's Perspective: Physicochemical and in vitro Parameters Relevant for Drug Discovery
    作者:Marcus Frings、Carsten Bolm、Andreas Blum、Christian Gnamm
    DOI:10.1016/j.ejmech.2016.09.091
    日期:2017.1
    Sulfoximines, sulfondiimides and sulfonimidamides are fascinating but not yet fully explored variants of the common sulfone or sulfonamide motif. In this study, we report the physicochemical and in vitro properties of sulfoximines and compare them with related analogs and isosteres. Furthermore, we present a matched molecular pair analysis of compounds from drug discovery projects within Boehringer Ingelheim. We demonstrate that the sulfoximine moiety is a chemically stable, comparatively polar and weakly basic functional group, often leading to favorable aqueous solubility, permeability and metabolic stability. Moreover, their additional vectors at nitrogen enable simple chemical modifications and thus facilitate exploration and fine-tuning of the molecular properties. We conclude that sulfoximines and their congeners do not exhibit any intrinsic flaw but significantly enrich the toolbox of medicinal chemists. (C) 2016 Elsevier Masson SAS. All rights reserved.
  • Mild Copper–TBAF-Catalyzed <i>N</i>-Arylation of Sulfoximines with Aryl Siloxanes
    作者:Jaeeun Kim、Jinpyo Ok、Sanghyuck Kim、Wonseok Choi、Phil Ho Lee
    DOI:10.1021/ol502174n
    日期:2014.9.5
    An efficient copper-TBAF-catalyzed C-N bond formation of sulfoximines with arylsiloxanes in dichloromethane at room temperature, affording the desired N-aryl sulfoximines in good to excellent yields under an oxygen atmosphere, is reported. This method complements the existing synthetic approaches due to some advantageous properties of arylsiloxanes such as availability, low toxicity, ease of handling, high stability, and environmental benignity under mild reaction conditions, thus opening a new approach to practical C-N bond formation.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫